ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies.

Pinkal Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.